Skip to main content

Financial news

The newsroom

Headlines from the Federal Reserve, ECB, Bank of Japan, Bank of England, SEC EDGAR, the White House and the DOJ. Context notes are neutral and information-only, Kresmion publishes no buy or sell recommendations.

Public RSS feeds · refreshed every 30 minutes

7889 items from SEC EDGAR · clear filters

  • SEC EDGAR•filings
    8-K - FF EAI Robotics Ecosystem Inc. (0001460702) (Filer)

    FF EAI Robotics Ecosystem Inc. filed an 8-K on October 14, 2026, reporting entry into a material definitive agreement, unregistered sales of equity securities, a Regulation FD disclosure, and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - STATE STREET CORP (0000093751) (Filer)

    State Street Corp filed an 8-K on Oct. 14, 2026, reporting its results of operations and financial condition, changes to directors and officers, related compensation arrangements, a Regulation FD disclosure, and accompanying financial statements.

  • SEC EDGAR•filings
    8-K - Karyopharm Therapeutics Inc. (0001503802) (Filer)

    Karyopharm Therapeutics Inc. filed a Form 8-K with the SEC on October 14, 2026, reporting an Item 8.01 “Other Events.”

  • SEC EDGAR•filings
    8-K - Aquestive Therapeutics, Inc. (0001398733) (Filer)

    Aquestive Therapeutics filed an 8-K on October 14, 2026, reporting entry into a material definitive agreement and providing its financial statements and related exhibits.

  • SEC EDGAR•filings
    8-K - Eton Pharmaceuticals, Inc. (0001710340) (Filer)

    Eton Pharmaceuticals filed an 8-K reporting entry into a material definitive agreement, completion of an acquisition or asset disposition, and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - SONO TEK CORP (0000806172) (Filer)

    Sono Tek Corp filed a Form 8-K on October 14, 2026, reporting its results of operations and financial condition, providing a Regulation FD disclosure, and attaching its financial statements and related exhibits.

  • SEC EDGAR•filings
    8-K - Xeris Biopharma Holdings, Inc. (0001867096) (Filer)

    Xeris Biopharma Holdings, Inc. filed a Form 8-K with the SEC on October 14, 2026, reporting under Item 8.01 (Other Events). The filing, accession number 0001867096-26-000091, is 170 KB in size.

  • SEC EDGAR•filings
    8-K - ENTEGRIS INC (0001101302) (Filer)

    Entegris Inc. filed a Form 8-K under Item 8.01 (Other Events) on October 14, 2026, accession number 0001101302-26-000154, with a document size of 276 KB.

  • SEC EDGAR•filings
    8-K - XTI Aerospace, Inc. (0001529113) (Filer)

    XTI Aerospace filed a Form 8-K reporting departures and appointments of directors and officers, related compensatory arrangements, a Regulation FD disclosure, and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - Compass, Inc. (0001563190) (Filer)

    Compass, Inc. filed an 8-K on Oct. 14, 2026 reporting departures, elections, and appointments of directors or officers, related compensatory arrangements, and providing its financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - UNITED THERAPEUTICS Corp (0001082554) (Filer)

    United Therapeutics Corp filed a Form 8-K with the SEC on October 14, 2026, reporting Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).

  • SEC EDGAR•filings
    8-K - RANGE RESOURCES CORP (0000315852) (Filer)

    Range Resources Corp filed a Form 8-K on October 14, 2026, disclosing its results of operations and financial condition for the reporting period.

  • SEC EDGAR•filings
    8-K - BANK OF AMERICA CORP /DE/ (0000070858) (Filer)

    Bank of America Corp filed an 8-K on October 14, 2026 (AccNo 0000070858-26-000481, 16 MB), containing Item 2.02 results of operations and financial condition, Item 7.01 Regulation FD disclosure, and Item 9.01 financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - Accenture plc (0001467373) (Filer)

    Accenture plc filed a Form 8-K on October 14, 2026, containing a Regulation FD disclosure (Item 7.01) and accompanying financial statements and exhibits (Item 9.01).

  • SEC EDGAR•filings
    8-K - NATIONAL FUEL GAS CO (0000070145) (Filer)

    National Fuel Gas Co filed a Form 8-K on October 14, 2026 (Accession No. 0001193125-26-420980), containing a Regulation FD disclosure, other events, and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - BlackRock, Inc. (0002012383) (Filer)

    BlackRock, Inc. filed a Form 8-K on October 14, 2026, containing Item 2.02 results of operations and financial condition, Item 7.01 Regulation FD disclosure, and Item 9.01 financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - Quoin Pharmaceuticals Ltd. (0001671502) (Filer)

    Quoin Pharmaceuticals Ltd. filed a Form 8-K on October 14, 2026, including a Regulation FD disclosure, other events, and financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - Verastem, Inc. (0001526119) (Filer)

    Verastem, Inc. filed a Form 8-K on October 14, 2026, reporting results of operations and financial condition, director/officer departures, elections, appointments and compensation arrangements, a Regulation FD disclosure, other events, and accompanying financial statements.

  • SEC EDGAR•filings
    8-K - FortuneX Acquisition Corp (0002121703) (Filer)

    FortuneX Acquisition Corp filed a Form 8-K on October 14, 2026, reporting entry into a material definitive agreement and providing its financial statements and related exhibits.

  • SEC EDGAR•filings
    8-K - Artificial Intelligence Technology Solutions Inc. (0001498148) (Filer)

    Artificial Intelligence Technology Solutions Inc. filed a Form 8-K on October 14, 2026, reporting other events and providing its financial statements and related exhibits.

  • SEC EDGAR•filings
    8-K - Liquidia Corp (0001819576) (Filer)

    Liquidia Corp filed a Form 8-K on October 14, 2026, reporting entry into and termination of material definitive agreements, providing a Regulation FD disclosure, other events, and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - NEWS CORP (0001564708) (Filer)

    News Corp filed a Form 8-K on October 14, 2026 (Accession No. 0001564708-26-000221), containing Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).

  • SEC EDGAR•filings
    8-K - TRAFALGAR INTERNATIONAL, INC. (0001695473) (Filer)

    Trafalgar International, Inc. filed a Form 8-K reporting amendments to its articles of incorporation or bylaws, a change in its fiscal year, other events, and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - Pioneer Acquisition I Corp (0002040381) (Filer)

    Pioneer Acquisition I Corp filed a Form 8-K on October 14, 2026, reporting entry into a material definitive agreement, a Regulation FD disclosure, and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - ENERGY FUELS INC (0001385849) (Filer)

    Energy Fuels Inc. filed a Form 8-K on October 14, 2026, including Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits) under accession number 0001062993-26-005311.

  • SEC EDGAR•filings
    8-K - Biomea Fusion, Inc. (0001840439) (Filer)

    Biomea Fusion, Inc. submitted an 8-K filing on October 14, 2026 (AccNo 0001193125-26-420684), containing a Regulation FD disclosure, other events, and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - Sadot Group Inc. (0001701756) (Filer)

    Sadot Group Inc. filed a Form 8-K on October 13, 2026, reporting a material definitive agreement, other events, and accompanying financial statements and exhibits.

  • SEC EDGAR•filings
    8-K - VisionWave Holdings, Inc. (0002038439) (Filer)

    VisionWave Holdings, Inc. filed a Form 8-K reporting the termination of a material definitive agreement, unregistered sales of equity securities, and the inclusion of financial statements and related exhibits.

  • SEC EDGAR•filings
    8-K - REDWOOD TRUST INC (0000930236) (Filer)

    Redwood Trust Inc. filed a Form 8-K on October 13, 2026, reporting its results of operations and financial condition, providing a Regulation FD disclosure, and attaching its financial statements and related exhibits.

  • SEC EDGAR•filings
    8-K - DataMeds AI, Inc. (0002030763) (Filer)

    DataMeds AI, Inc. filed a Form 8-K reporting an Item 8.01 “Other Events” on October 13, 2026, accession number 0001493152-26-046887, with a filing size of 201 KB.